As your Representative, I will continue to bring attention and support causes that increase awareness and deliver resources to those who need it most.
Continue to bring attention and support causes that increase mental health awareness and deliver resources.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
"2/17/23 | Congresswoman Lisa McClain to Co-Chair Bipartisan Mental Health and Substance Use Disorder Task Force"
legacy_unverified · Source version not recorded · locator unknown
"Bipartisan Addiction and Mental Health Task Force"
legacy_unverified · Source version not recorded · locator unknown
"Renewing this legislation reaffirms our commitment to providing the necessary tools and resources to combat this crisis, support those in recovery, and save lives"
unverified · Source version 56151 · locator unknown
McClain hosted a fentanyl-crisis roundtable with federal partners, recovery advocates, health care professionals, law enforcement, and impacted families, and said prevention, recovery programs, community partnerships, and family resources remain needed.
legacy_unverified · Source version not recorded · locator unknown
GovInfo lists H.R. 2483 as Public Law 119-44, approved December 1, 2025, to reauthorize opioid use disorder prevention, treatment, and recovery programs; legislative history shows House passage on June 4 and Senate passage on September 18, 2025.
Assessments
McClain continued public attention to mental health-adjacent substance use and recovery issues through task force involvement and a 2026 fentanyl-crisis roundtable. More concretely, she publicly supported and voted for the SUPPORT for Patients and Communities Reauthorization Act, which became Public Law 119-44 on December 1, 2025, reauthorizing opioid use disorder prevention, treatment, and recovery programs. Her credit is shared with Congress rather than sole sponsorship, but the promise was broad and included supporting causes that deliver resources, so this qualifies as delivered in the same federal term.
McClain has continued to bring attention to mental health and substance-use issues through membership/co-chair activity in the Bipartisan Addiction and Mental Health Task Force and by publicly supporting the SUPPORT for Patients and Communities Reauthorization Act of 2025, which passed the House and would continue opioid prevention, treatment, recovery, and comprehensive recovery center resources. That is meaningful federal same-term effort and some support for resource delivery, but the evidence does not show that she personally secured enacted resources or delivered a completed mental-health-awareness/resource outcome attributable enough for full delivery.